US bank regulators on Tuesday said that cryptoassets and exposure present risks to lenders, urging organizations to ensure they manage the dangers.
The joint statement came after the sudden collapse of cryptocurrency platform FTX — worth US$32 billion before it filed for bankruptcy in November — which sent chills across the sector.
FTX’s disgraced founder Sam Bankman-Fried has since been accused of committing one of the biggest financial frauds in US history, sparking calls for greater oversight.
“It is important that risks related to the crypto-asset sector that cannot be mitigated or controlled do not migrate to the banking system,” the US Federal Reserve, Federal Deposit Insurance Corp and the US Office of the Comptroller of the Currency said.
They added in a joint statement that events of the past year “have been marked by significant volatility and the exposure of vulnerabilities in the crypto-asset sector.”
Banking organizations should be aware of risks such as fraud and scams, along with inaccurate or misleading disclosures, the agencies said.
There is also “significant volatility” in cryptoasset markets, and contagion risk in the sector due to connections between parties — including through opaque lending, investing or funding.
The watchdogs said they continue to take a “careful and cautious approach” with crypto activities and exposure at banking organizations.
Meanwhile, lenders should “ensure appropriate risk management” such as board oversight and guardrails to identify and manage threats, the statement said.
FTX’s implosion was swift following a Nov. 2 media report on ties between it and Alameda Research, a trading company also controlled by Bankman-Fried.
The report exposed that Alameda Research’s balance sheet was heavily built on the FTT currency — a token created by FTX with no independent value — and exposed Bankman-Fried’s companies as being dangerously interlinked.
Separately, Bankman-Fried on Tuesday pleaded not guilty to US criminal fraud charges over the spectacular collapse of his crypto exchange.
The 30-year-old former digital currency billionaire, who is out on bail, entered the plea in federal court in Manhattan before New York Judge Lewis Kaplan.
He was arrested at his apartment in the Bahamas — where FTX is headquartered — on Dec. 12 at the request of the federal prosecutors in New York.
He spent nine days in prison in the island country before being extradited to the US, where he appeared in court last month. He was released on a US$250 million bail package that requires him to live at his parents’ home in California. He is also subject to electronic monitoring.
The US government has charged Bankman-Fried with conspiracy, wire fraud, money laundering and election finance breaches.
Prosecutors have alleged that he cheated investors and misused funds that belonged to FTX and Alameda Research clients.
Bankman-Fried pleaded not guilty to all eight counts against him — five of which carry a maximum sentence of 20 years in prison each.
Kaplan set a tentative date of Oct. 2 for the start of his trial.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining